DA
Dunvegan Associates’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | $75K | Sell |
1,468
-178
| -11% | -$9.09K | 0.09% | 76 |
|
|
2015
Q3 | $77K | Buy |
1,646
+823
| +100% | +$38.5K | 0.09% | 75 |
|
|
2015
Q2 | $103K | Hold |
823
| – | – | 0.11% | 67 |
|
|
2015
Q1 | $102K | Hold |
823
| – | – | 0.09% | 85 |
|
|
2014
Q4 | $89K | Sell |
823
-164
| -17% | -$17.7K | 0.08% | 82 |
|
|
2014
Q3 | $105K | Hold |
987
| – | – | 0.09% | 74 |
|
|
2014
Q2 | $102K | Hold |
987
| – | – | 0.09% | 77 |
|
|
2014
Q1 | $92K | Buy |
+987
| New | +$92K | 0.08% | 78 |
|